Literature DB >> 3872456

Role of the Bp35 cell surface polypeptide in human B-cell activation.

E A Clark, G Shu, J A Ledbetter.   

Abstract

A 35-kDa polypeptide, Bp35, expressed on the surface of all B cells, plays a role in B-cell activation. Monoclonal antibodies to Bp35 stimulate human tonsillar B cells to proliferate. The activation induced by anti-Bp35 is similar to anti-Ig-mediated in several ways: the activation does not require T cells but is augmented by T-cell-derived allogeneic factors; monovalent Fab fragments to Bp35 do not trigger proliferation but instead block activation by whole antibody, indicating that cross-linking is required; and induction by anti-Bp35, like the induction by anti-Ig, is inhibited by monoclonal anti-IgM via an Fc domain-dependent mechanism. However, several features of anti-Bp35-mediated proliferation are clearly different from activation by anti-Ig: anti-Bp35 monoclonal antibodies do not require attachment to beads to function, the proliferation induced by anti-Bp35 and anti-Ig is additive, and Fab fragments of anti-Bp35 augment proliferation induced by anti-Ig. Models for the possible function of the Bp35 polypeptide as either a "bridge" or a "second signal" with surface Ig in B-cell activation are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872456      PMCID: PMC397353          DOI: 10.1073/pnas.82.6.1766

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  Thymus-independent B-cell induction and paralysis.

Authors:  A Coutinho; G Möller
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

Review 2.  Human B cell activation, proliferation and differentiation.

Authors:  J H Kehrl; A Muraguchi; J L Butler; R J Falkoff; A S Fauci
Journal:  Immunol Rev       Date:  1984-04       Impact factor: 12.988

Review 3.  The synergism of accessory cells and of soluble alpha-factors derived from them in the activation of B cells to proliferation.

Authors:  C Corbel; F Melchers
Journal:  Immunol Rev       Date:  1984-04       Impact factor: 12.988

4.  Further biochemical studies of the human B-cell differentiation antigens B1 and B2.

Authors:  H C Oettgen; P J Bayard; W Van Ewijk; L M Nadler; C P Terhorst
Journal:  Hybridoma       Date:  1983

5.  Differential expression of cell activation markers after stimulation of resting human B lymphocytes.

Authors:  J H Kehrl; A Muraguchi; A S Fauci
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

6.  Inhibition of mitogenic stimulation of mouse lymphocytes by anti-mouse immunoglobulin antibodies. I. Mode of action.

Authors:  J Andersson; W W Bullock; F Melchers
Journal:  Eur J Immunol       Date:  1974-11       Impact factor: 5.532

7.  A theory of self-nonself discrimination.

Authors:  P Bretscher; M Cohn
Journal:  Science       Date:  1970-09-11       Impact factor: 47.728

8.  Human T lymphocyte activation by monoclonal antibodies; OKT3, but not UCHT1, triggers mitogenesis via an interleukin 2-dependent mechanism.

Authors:  J P Van Wauwe; J G Goossens; P C Beverley
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

9.  B cell activation. IV. Induction of cell membrane depolarization and hyper-I-A expression by phorbol diesters suggests a role for protein kinase C in murine B lymphocyte activation.

Authors:  J G Monroe; J E Niedel; J C Cambier
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

10.  STUDIES ON RABBIT LYMPHOCYTES IN VITRO. I. STIMULATION OF BLAST TRANSFORMATION WITH AN ANTIALLOTYPE SERUM.

Authors:  S SELL; P G GELL
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

View more
  38 in total

Review 1.  CD20-mediated apoptosis: signalling through lipid rafts.

Authors:  Julie P Deans; Haidong Li; Maria J Polyak
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

2.  Distinct patterns of transmembrane calcium flux and intracellular calcium mobilization after differentiation antigen cluster 2 (E rosette receptor) or 3 (T3) stimulation of human lymphocytes.

Authors:  C H June; J A Ledbetter; P S Rabinovitch; P J Martin; P G Beatty; J A Hansen
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

Review 3.  Functional B-lymphocyte surface antigens.

Authors:  J T Golay
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

4.  Targeted cell entry of lentiviral vectors.

Authors:  Sabrina Funke; Andrea Maisner; Michael D Mühlebach; Ulrike Koehl; Manuel Grez; Roberto Cattaneo; Klaus Cichutek; Christian J Buchholz
Journal:  Mol Ther       Date:  2008-06-24       Impact factor: 11.454

5.  Beta 2-integrin LFA-1 signaling through phospholipase C-gamma 1 activation.

Authors:  S B Kanner; L S Grosmaire; J A Ledbetter; N K Damle
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

6.  Patterns of expression, membrane localization, and effects of ectopic expression suggest a function for MS4a4B, a CD20 homolog in Th1 T cells.

Authors:  Hui Xu; Mark S Williams; Lisa M Spain
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

7.  NDA3: a differentiation antigen associated with the receptor for B cell growth factor.

Authors:  N Suciu-Foca; C Rohowsky-Kochan; S J Rosochacki; E Cristea; J D Cai; E Reed; D W King
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

8.  Pathways of human B-lymphocyte activation blocked by B-cell specific monoclonal antibodies.

Authors:  J T Golay; D H Crawford
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

9.  Rituximab for non-Hodgkin's lymphoma: a story of rapid success in translation.

Authors:  Andrew M Harrison; Nassir M Thalji; Alexandra J Greenberg; Carmen J Tapia; Anthony J Windebank
Journal:  Clin Transl Sci       Date:  2013-10-03       Impact factor: 4.689

10.  T-cell activation influences initial DNA synthesis of simian immunodeficiency virus in resting T lymphocytes from macaques.

Authors:  P S Polacino; H A Liang; E J Firpo; E A Clark
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.